Extrait

This study's purpose is to evaluate the long-term safety of open-label tolvaptan regimens to determine the maximally-tolerated dose and acquire pilot efficacy data in patients with ADPKD.

Critère d'inclusion

• Polycystic kidney, autosomal dominant

Liens

• ictrp
• nct